Abstracts Archive - Page 1395 of 2607 - ACR Meeting Abstracts

Abstract Number: 115 • 2017 ACR/ARHP Annual Meeting
Training the Next Generation of Investigative Rheumatologists: Results of the Usbji’s Young Investigator Initiative for Academic Rheumatologists
Nancy E. Lane¹, Ann Rosenthal², Howard Hillstrom³ and Edward Puzas⁴, ¹Center for Musculoskeletal Health, University of California, Davis School of Medicine, Sacramento, CA, ²Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, ³orthopedics, Hospital for special surgery, New York City, NY, ⁴Orthopedic Surgery, University of Rochester School of Medicine, Rochester, NY
Background/Purpose: The success of a physician scientist in academic rheumatology requires effective skills to obtain peer-reviewed funding. The number of NIH-funded junior investigators is low…
Abstract Number: 116 • 2017 ACR/ARHP Annual Meeting
Immunotherapy-Induced Rheumatic Disease: How Prepared Are Rheumatologists to Address This Emerging Condition?
Laura Cappelli^1,2, Cassandra Calabrese³, Leonard H. Calabrese³ and Clifton O. Bingham III⁴, ¹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Medicine/Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Rheumatic & Immunologic Disease, Cleveland Clinic Foundation, Cleveland, OH, ⁴Rheumatology, Johns Hopkins University, Baltimore, MD
Background/Purpose: Cancer immunotherapy targeting immune checkpoints represents a major advance in oncology, yet has been associated with immune-related adverse events (IRAEs) affecting many organ systems,…
Abstract Number: 117 • 2017 ACR/ARHP Annual Meeting
Using Goutpro to Make Medical Trainees Gout Pros- a Single Blinded Randomized Control Study
Linh Ngo¹, Eric Miller², Peter A. Valen³ and Alisa Duran⁴, ¹Division of Rheumatology, University of Minnesota, Minneapolis, MN, ²Medicine, Hennepin County Medical Center, Minneapolis, MN, ³Rheumatology/ Dept of Medicine, University of Minnesota/Minneapolis VAMC, Minneapolis, MN, ⁴Department of Medicine, University of Minnesota, Minneapolis, MN
Background/Purpose: Gout is the most common type of inflammatory arthritis in the U.S., affecting 4% of the population. Despite modern advancements and the availability of…
Abstract Number: 118 • 2017 ACR/ARHP Annual Meeting
Experiences and Perceptions of Patients with Rheumatoid Arthritis Participating in an Online Support Group: The Use of Social Media
Jude K. A. des Bordes¹, Jessica Foreman¹, Susan K. Peterson², Maria A. Lopez-Olivo³, Tiffany Westrich-Robertson⁴, Catherine Hofstetter⁵, Anne Lyddiatt⁶, Amye L. Leong⁷ and Maria Suarez-Almazor³, ¹Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, Houston, TX, ²Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston Texas, USA, Houston, TX, ³Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, ⁴International Foundation for Autoimmune and Autoinflammatory Arthritis, Saint Louis, Missouri, USA, St Louis, MO, ⁵Canadian Arthritis Patients Alliance (CAPA), Toronto Ontario, Canada, Toronto, ON, Canada, ⁶Musculoskeletal Group, Cochrane Collaboration, Hamilton, ON, Canada, ⁷Spokesperson; Strategic Relations, Bone and Joint Decade, Santa Barbara, CA
Background/Purpose: Providing social support is an important component in the management of chronic diseases. In rheumatoid arthritis (RA), peer support is particularly important for coping…
Abstract Number: 119 • 2017 ACR/ARHP Annual Meeting
Occupational Exposure to Asbestos and Risk of Rheumatoid Arthritis
Anna Ilar¹, Per Gustavsson¹, Pernilla Wiebert¹, Camilla Bengtsson¹, Lars Klareskog² and Lars Alfredsson¹, ¹The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ²Rheumatology unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Due to the known association between silica dust and rheumatoid arthritis (RA), we wanted to study the association between RA and another silicate mineral;…
Abstract Number: 120 • 2017 ACR/ARHP Annual Meeting
Patients with Rheumatoid Arthritis Have Higher Lifetime Professional and Non-Professional Exposure to Silica Dust Particles Compared to General Population
Luca Semerano^1,2,3, Catherine Cavalin^4,5,6, Odile Macchi^4,7, Sara El Rharras³, Mylene Petit³, Patrice Decker^8,9, Emma Andre¹⁰, Paul André Rosental^4,11 and Marie-Christophe Boissier¹², ¹UMR 1125, Inserm, Bobigny, France, ²EA4222, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, ³Service de Rhumatologie, Assistance Publique – Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne - Jean Verdier – René Muret, Bobigny, France, ⁴SILICOSIS project, ERC Advanced Grant, Centre for European Studies, Sciences Po, Paris, France, ⁵Centre for Employment and Labour Studies (CNAM), Noisy-le-Grand, France, ⁶Laboratory for Interdisciplinary Evaluation of Public Policies (LIEPP, Sciences Po, Paris), Paris, France, ⁷Centre for Historical Research, CNRS-EHESS, Paris, France, ⁸Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, ⁹UMR 1125, INSERM, Bobigny, France, ¹⁰UMR1125, Inserm, Bobigny, France, ¹¹National Institute for Demographic Studies (INED), Paris, France, ¹²74 rue Marcel Cachin, INSERM, Bobigny, France
Background/Purpose: Occupational exposure to silica dust has been associated with increased risk of developing ACPA positive Rheumatoid arthritis (RA)1,2,3. Little is known about non-occupational exposure,…
Abstract Number: 121 • 2017 ACR/ARHP Annual Meeting
Depression As a Risk Factor for the Development of Rheumatoid Arthritis: A Population-Based Cohort Study
Isabelle Vallerand¹, Ryan Lewinson², Mark Lowerison¹, Alexandra Frolkis³, Gilaad Kaplan³, Andrew Bulloch⁴, Scott Patten¹ and Cheryl Barnabe⁵, ¹Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²Biomedical Engineering Program, Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, ³Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ⁴Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ⁵Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: The underlying risk factors for the development of Rheumatoid Arthritis (RA) remain poorly understood; however, prospective studies have demonstrated that individuals with elevated Tumor…
Abstract Number: 122 • 2017 ACR/ARHP Annual Meeting
Poor Prognostic Factors at the Start of Methotrexate Therapy Are Not Associated with Worse Treatment Response: Results from the Rheumatoid Arthritis Medication Study
JM Gwinnutt¹, Kimme L. Hyrich¹, M Lunt¹, Darren Plant¹, M Brazil², R Postema², Anne Barton¹ and Suzanne M Verstappen¹, ¹Manchester Academic Health Science Centre, Manchester, United Kingdom, ²Bristol-Myers Squibb, Uxbridge, United Kingdom
Background/Purpose: As anti-citrullinated protein antibody positivity (+), RF+ and erosions are independently associated with poor outcomes in patients (pts) with RA, clinicians may use these…
Abstract Number: 123 • 2017 ACR/ARHP Annual Meeting
Relationship between Shift Work and the Onset of Rheumatoid Arthritis; Results from a Swedish Case-Control Study
Lars Alfredsson¹, Anna Karin Hedström², Torbjörn Åkerstedt³ and Lars Klareskog⁴, ¹The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ²Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ³Stockholm University; Karolinska Intitutet, Stockholm, Sweden, ⁴Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Background/Purpose: Shift work has previously been associated with increased RA risk in females. The aim of this study was to investigate the potential association between…
Abstract Number: 124 • 2017 ACR/ARHP Annual Meeting
Smoking and Rheumatoid Arthritis Susceptibility; Quantification of the Impact of Cumulative Dose, Frequency and Duration of Smoking, and Smoking Cessation
Lars Alfredsson¹, Anna Karin Hedström², Camilla Bengtsson³ and Lars Klareskog⁴, ¹The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ²Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ³Inst of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁴Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Background/Purpose: Smoking is one of the most established risk factors for rheumatoid arthritis (RA). The aim of this study was to estimate how age at…
Abstract Number: 125 • 2017 ACR/ARHP Annual Meeting
Exposure to Passive Smoking and RA Risk; Results from a Swedish Case-Control Study
Lars Alfredsson¹, Anna Karin Hedström² and Lars Klareskog³, ¹The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ²Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ³Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Background/Purpose: Smoking has consistently been associated with increased risk of developing rheumatoid arthritis (RA). We investigated the influence of passive smoking on the risk of…
Abstract Number: 126 • 2017 ACR/ARHP Annual Meeting
Smoking Is Causally Associated with Disease Activity in Rheumatoid Arthritis
Milena Gianfrancesco¹, Laura Trupin², Stephen Shiboski³, Mark van der Laan⁴, Jonathan Graf⁵, John B. Imboden Jr.⁶, Jinoos Yazdany² and Gabriela Schmajuk⁷, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ³Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁴University of California, Berkeley, Berkeley, CA, ⁵Department of Medicine, Division of Rheumatology Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, ⁶Medicine, University of California, San Francisco, San Francisco, CA, ⁷San Francisco VA Medical Center, University of California San Francisco, San Francisco, CA
Background/Purpose: The association between smoking and risk of rheumatoid arthritis (RA) has been well documented; however, the relationship between smoking and RA disease activity is…
Abstract Number: 127 • 2017 ACR/ARHP Annual Meeting
Diet Change and Omega-3 Supplementation in the First Three Years Following a Diagnosis with Rheumatoid Arthritis in Sweden
Maxine Lancelot^1,2, Olivier Grimaud³, Saedis Saevarsdottir⁴, Johan Askling⁵, Lars Klareskog⁶, Lars Alfredsson⁷ and Camilla Bengtsson⁸, ¹IMM, Karolinska Institutet, Stockholm, Sweden, ²EHESP, Paris, France, ³EHESP, Rennes, France, ⁴Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, ⁵Unit of Clinical Epidemiology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, ⁶Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, ⁷The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁸Inst of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Major dietary modification and omega-3 supplements are often promoted on patient counseling websites for those with RA. Given uncertainty regarding such approaches, we aim…
Abstract Number: 128 • 2017 ACR/ARHP Annual Meeting
Use of Machine Learning and Traditional Statistical Methods to Classify RA-Related Disability Using Administrative Claims Data
Jeffrey R. Curtis¹, Huifeng Yun², Carol J. Etzel³, Shuo Yang⁴ and Lang Chen⁴, ¹Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³Departments of Epidemiology and Biostatistics, University of Texas School of Public Health, Houston, TX, ⁴Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Administrative claims and electronic health record (EHR) data are commonly used to assess outcomes in rheumatoid arthritis (RA). However, direct measures of functional status…
Abstract Number: 129 • 2017 ACR/ARHP Annual Meeting
Impact of the Multi-Biomarker Disease Activity Score Results on Whether Rheumatologists Changed Biologic Therapy for RA Patients
Jeffrey R. Curtis¹, Kerri Ford², Lang Chen³, Huifeng Yun³ and Fenglong Xie⁴, ¹Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ²Crescendo Bioscience Inc., South San Francisco, CA, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The multi-biomarker disease activity (MBDA) score is a validated test used to assess disease activity for patients with rheumatoid arthritis (RA). How it is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].